J&J acquires Yellow Jersey Therapeutics for US$1.25B to bolster atopic dermatitis pipeline
USA— Johnson & Johnson (J&J), headquartered in New Brunswick, has finalized its US$1.25...
Read More
Tag: J&J
J&J invests US$850M in Proteologix acquisition to enhance dermatology portfolio
USA – Johnson & Johnson (J&J) has announced a definitive agreement to acquire...
Read More
FDA grants conditional approval for J&J’s innovative bispecific antibody medicine
USA —The US Food and Drug Administration (FDA) has granted conditional approval for a cutting-edge...
Read More
Johnson & Johnson sued by Kenyan consumer advocacy group over the sale of talc-based baby powder
KENYA — The African Centre for Corrective and Preventive Action (ACCPA) has sued U.S.-based...
Read More
Johnson & Johnson reportedly targeting a US$40 billion valuation for consumer health unit Kenvue
USA — Johnson & Johnson is aiming for a valuation of US$40 billion for its consumer health...
Read More
Johnson & Johnson reports 10% sales increase in the U.S. and raises dividend
USA — Johnson & Johnson, the multinational healthcare company, has reported first-quarter...
Read More
J&J to pay US$8.9 billion to settle legal claims regarding talcum powder
USA — Johnson & Johnson has taken a significant step towards resolving the allegations that...
Read More
Sanofi’s global head of R&D leaves for a similar role at J&J
FRANCE — Sanofi’s global head of R&D, John Reed has stepped down from his role in the company...
Read More
DePuy Synthes to pay US$9.75 million to settle surgeon kickbacks case
USA — DePuy Synthes, a subsidiary of healthcare company Johnson & Johnson has agreed to pay...
Read More
J&J & SciBase collaborate to develop skin-screening AI to predict eczema in newborns
USA — SciBase, a developer of augmented intelligence-based solutions for skin disorders has signed...
Read More
LATEST DIGITAL MAGAZINE
